Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia

BACKGROUND: The aim of this study was to investigate the efficacy of etanercept treatment and to identify predictors of response to therapy within 12 months in patients with juvenile idiopathic arthritis (JIA) without systemic manifestations. METHODS: A total of 197 juvenile patients were enrolled i...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexeeva, Ekaterina I., Namazova-Baranova, Leyla S., Bzarova, Tatyana M., Valieva, Saniya I., Denisova, Rina V., Sleptsova, Tatyana V., Isaeva, Kseniya B., Chomahidze, Alexandra M., Taibulatov, Nikolay I., Fetisova, Anna N., Karaseva, Anna V., Baranov, Alexandr A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471744/
https://www.ncbi.nlm.nih.gov/pubmed/28615036
http://dx.doi.org/10.1186/s12969-017-0178-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471744/
https://www.ncbi.nlm.nih.gov/pubmed/28615036
http://dx.doi.org/10.1186/s12969-017-0178-9

Ejemplares similares